Product Information

URSODIOL 300 MG CAPSULE is a generic product labeled by PuraCap Laboratories LLC, priced at $0.4425 per EA under NDC 24658078001. Its NADAC has been published 497 times since May 17, 2017.

FDA first approved this application on Mar 14, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

URSODIOL 300 MG CAPSULE

Ursodiol
$0.4425per EA

Strength

300 mg/1

NDC

24658078001

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

URSODIOL

Approval Type

Generic (ANDA)

FDA Application

ANDA075517

FDA Approved

3/14/2000

TE Code

AB

On Market Since

12/15/2016

Pharmacological Classes

Bile Acid
Bile Acids and Salts

Price Statistics

The NADAC for URSODIOL 300 MG CAPSULE has been published 497 times since May 17, 2017, and over the history we have for it it has declined 86.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4425 per EA
All-time high$3.3524 (Aug 16, 2017)
All-time low$0.3666 (Jul 17, 2024)
52-week high$0.4703
52-week low$0.4160
Median price$0.5976
Average price$0.9969
Largest weekly change+30.7% (Aug 21, 2024)
Weeks tracked497
Tracking sinceMay 17, 2017

Price History

1W

+2.1%

1M

+3.1%

3M

+6.3%

6M

-1.5%

1Y

+3.4%

3Y

-19.8%

5Y

-22.7%

All

-86.7%

Generic Alternatives

The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of URSODIOL 300 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for URSODIOL 300 MG CAPSULE, manufactured by PuraCap Laboratories LLC, is $0.4425 per EA (NDC 24658078001), effective Nov 18, 2026.

How has the price of URSODIOL 300 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for URSODIOL 300 MG CAPSULE has declined 86.7%. It has been tracked across 497 weekly CMS publications since May 17, 2017.

What are the highest and lowest recorded NADAC prices for URSODIOL 300 MG CAPSULE?

Since May 17, 2017, the NADAC for URSODIOL 300 MG CAPSULE has ranged from a low of $0.3666 (Jul 17, 2024) to a high of $3.3524 (Aug 16, 2017), with a median of $0.5976 per EA.

Are there cheaper alternatives to URSODIOL 300 MG CAPSULE?

Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, URSODIOL 300 MG CAPSULE, is $0.4160 per EA — about 6% below URSODIOL 300 MG CAPSULE.

Who manufactures URSODIOL 300 MG CAPSULE?

URSODIOL 300 MG CAPSULE (NDC 24658078001) is labeled by PuraCap Laboratories LLC, and CMS classifies it as a generic product.